Home
Gritstone Bio, Inc.

Gritstone Bio, Inc. Market Share Analysis for June 2026

Gritstone bio is a clinical-stage American biotechnology company which develops cancer and infectious disease immunotherapies and vaccines. It was founded in August 2015 as Gritstone Oncology, Inc., and is based in Emeryville, California. In September 2021 it raised $55.0 million from the sale of 5,000,000 shares.

Health > Biotechnology and Pharmaceuticals

Domaingritstonebio.com

Year Founded2015

Employees201 - 500

Annual Revenue$25M - $50M

Gritstone Bio, Inc.

Gritstone Bio, Inc. (including company regionals)

gritstonebio.com

See more website traffic and engagement information

Gritstone Bio, Inc. Revenue up to June 2026 is 25M - 50M

revenue generated by Gritstone Bio, Inc. top domains

Gritstone Bio, Inc. top domains revenue over 3 years

Revenue for Gritstone Bio, Inc. top domains

gritstonebio.com25M - 50M

See more with Sales Intelligence

Total visits to Gritstone Bio, Inc.'s top domains

Understand Gritstone Bio, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gritstonebio.com--

See more with Sales Intelligence

Avg. visit duration in Gritstone Bio, Inc.'s top domains

Analyze Gritstone Bio, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Gritstone Bio, Inc.'s top domains

See how Gritstone Bio, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gritstonebio.com--

See more with Sales Intelligence

Gritstone Bio, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Gritstone Bio, Inc.

These are the website technologies, by industry, used by Gritstone Bio, Inc. top domains

Widget (3)

Twemoji

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

Audio Video Media (1)

Vimeo

More Technologies

5

See all

News & Signals from Gritstone Bio, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRousseau left Gritstone bio, Inc. as Executive Vice President, Head of Product Development, and Chief Medical Officer on Jan 1st '25.Dr. Rousseau most recently served as Executive Vice President, Head of Product Development, and Chief Medical Officer at Gritstone bio, where he was responsible for the company's global clinical development strategies and expansion of its neoantigen-based immunotherapies.

NewsGritstone bio, Inc. has issues with Chapter 11 bankruptcy case.ArentFox Schiff has been selected as counsel for the Official Committee of Unsecured Creditors in the Chapter 11 bankruptcy case of Gritstone bio, Inc.

NewsBragar Eagel & Squire PC files suit against Gritstone bio, Inc..Bragar Eagel & Squire, P.C. Reminds investors that class action lawsuits have been filed against Gritstone, Roblox, and Rivian and encourages investors to contact the firm.